open access

Vol 9, No 1 (2014)
Review Papers
Published online: 2014-03-19
Get Citation

Heart failure and atrial fibrillation — the lethal duo of modern cardiology

Maciej Krzysztof Kluk, Beata Wożakowska-Kapłon
Folia Cardiologica 2014;9(1):67-73.

open access

Vol 9, No 1 (2014)
Review Papers
Published online: 2014-03-19

Abstract

Heart failure (HF) and atrial fibrillation (AF) are currently considered to be significant and frequent cardiovascular complications of gradually extending lifetime and progress in medicine. Due to common risk factors and pathomechanisms, they frequently coexist in clinical practice. This coexistence multiplies the risk of complications and costs of treatment in this group of patients. The main common complications are thromboembolic incidents and escalation of heart muscle damage. Coexistence of HF and AF also decreases the effectiveness of treatment and quality of life. In therapy we use the same methods as in isolated forms of AF or HF, however additional thromboembolic risk and resistance to drugs should be always considered. The main present therapy issue is prevention of stroke due to cumulated thromboembolic risk, including new oral anticoagulants. The current recommendations of European Society of Cardiology in both AF and HF are also widely dedicated to this frequent clinically significant problem.

Abstract

Heart failure (HF) and atrial fibrillation (AF) are currently considered to be significant and frequent cardiovascular complications of gradually extending lifetime and progress in medicine. Due to common risk factors and pathomechanisms, they frequently coexist in clinical practice. This coexistence multiplies the risk of complications and costs of treatment in this group of patients. The main common complications are thromboembolic incidents and escalation of heart muscle damage. Coexistence of HF and AF also decreases the effectiveness of treatment and quality of life. In therapy we use the same methods as in isolated forms of AF or HF, however additional thromboembolic risk and resistance to drugs should be always considered. The main present therapy issue is prevention of stroke due to cumulated thromboembolic risk, including new oral anticoagulants. The current recommendations of European Society of Cardiology in both AF and HF are also widely dedicated to this frequent clinically significant problem.
Get Citation

Keywords

heart failure, atrial fibrillation, tachycardiomyopathy, new oral anticoagulants

About this article
Title

Heart failure and atrial fibrillation — the lethal duo of modern cardiology

Journal

Folia Cardiologica

Issue

Vol 9, No 1 (2014)

Pages

67-73

Published online

2014-03-19

Bibliographic record

Folia Cardiologica 2014;9(1):67-73.

Keywords

heart failure
atrial fibrillation
tachycardiomyopathy
new oral anticoagulants

Authors

Maciej Krzysztof Kluk
Beata Wożakowska-Kapłon

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl